Biotek-snakken — August 2020
-
God morgen.
-
-
SUTRO non-exe Director John Freud sells 500.000 shares at $8,72 for $4.360.000 Hmmm hvad skal man tænke om det ? https://www.sec.gov/Archives/edgar/data/1382101/000120919120047981/xslF345X03/doc4.xml
-
Svært - 1/4 af hans position så vidt jeg kan se. Det er vel fair i disse tider, at man sikre sig mod en større nedtur. Omvendt så burde de opdaterede data på STRO-002 give pæne kursstigninger, hvis der dukker responser op. Overvejede ellers lige at doble min position, men vil lige se hvorledes markedet reagerer på dette
-
Sutro modtager milestone betaling fra Merck for M1231 - beløbet er ikke umiddelbart dislosed. https://finance.yahoo.com/news/sutro-biopharma-earns-clinical-supply-110000665.html
-
"
The milestone was achieved with the delivery of GMP clinical trial supply to Merck KGaA, Darmstadt, Germany for the Phase 1 clinical trial testing of M1231 pursuant to a 2014 license agreement. As part of the agreement, Sutro will manufacture M1231 for early clinical supply and is eligible for further milestones and royalties. "
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind